COMP <GO>
ETN vs LRCX // EV/EBITDA & P/E VALUATION
Eaton Corporation PLC (NYSE) VS. Lam Research Corporation (NASDAQ) • 15-METRIC TALLY: ETN 7
— LRCX 7
▲ EV/EBITDA & P/E VALUATION LEADER: ETN
LAST: $369.97 (-6.03%) • MKT CAP: $152.92B
valuation
27.8x
LAST: $239.11 (-6.01%) • MKT CAP: $317.78B
valuation
34.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ETN VS. LRCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ETN | LRCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 37.60% | 50.50% | -12.90 | LRCX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.50% | 25.50% | -11.00 | LRCX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 27.8x | 34.8x | -7.00 | ETN | /valuation <GO> |
| Free Cash Flow Yield | 2.32% | 1.51% | +0.81 | ETN | /fcf-yield <GO> |
| Operating Margin | 18.20% | 35.30% | -17.10 | LRCX | /operating-margins <GO> |
| Net Profit Margin | 14.90% | 31.30% | -16.40 | LRCX | /net-margins <GO> |
| Revenue Growth (YoY) | 10.30% | 26.00% | -15.70 | LRCX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.06% | 0.40% | +0.66 | ETN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.15 | 21.80 | -15.65 | LRCX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | ETN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.6 | 41.7 | +5.90 | ETN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.37 | 1.29 | +0.08 | ETN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.8x | 36.7x | -1.90 | ETN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $152.92B | $317.78B | -$164.86B | LRCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ETN REV | LRCX REV | ETN GROSS % | LRCX GROSS % | ETN FCF | LRCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $27.45B | $23.23B | 37.6% | 50.5% | $3.55B | $4.81B |
| FY 2024 | $24.88B | $18.44B | 38.2% | 48.7% | $3.52B | $5.34B |
| FY 2023 | $23.20B | — | — | — | $2.58B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ETN // BETA 1.37
LRCX // BETA 1.29